CENTESSA PHARMACEUTICA

Centessa Pharmaceuticals Announces Third Quarter 2021 Financial Results and Business Updates

15 11 2021 06:00:03 提供 Nasdaq GlobeNewswire

Centessa Pharmaceuticals to Present at Upcoming Conferences in 2021

10 11 2021 15:45:00 提供 Nasdaq GlobeNewswire

Centessa Pharmaceuticals Demonstrates Proof-of-Mechanism from First Three PiMZ Subjects Dosed in Part B of Phase 1 Study Evaluating ZF874

01 11 2021 06:30:00 提供 Nasdaq GlobeNewswire

Centessa Pharmaceuticals Subsidiary, Orexia Therapeutics, and Schrödinger Announce Collaboration to Discover Novel Orexin Receptor Agonists

18 10 2021 07:00:01 提供 Nasdaq GlobeNewswire

Centessa Pharmaceuticals Appoints David Grainger, PhD, a Leading Biotech Entrepreneur, as Chief Innovation Officer

05 10 2021 07:00:01 提供 Nasdaq GlobeNewswire

Centessa Pharmaceuticals Announces $300 Million Financing Agreement with Oberland Capital

04 10 2021 07:00:01 提供 Nasdaq GlobeNewswire

Centessa Pharmaceuticals Announces Positive Topline Data from Proof-of-Concept Study of SerpinPC in Severe Hemophilia A and B Patients Not on Prophylaxis

09 9 2021 06:30:00 提供 Nasdaq GlobeNewswire

Centessa Pharmaceuticals to Present at the Morgan Stanley Virtual 19th Annual Global Healthcare Conference

01 9 2021 15:15:00 提供 Nasdaq GlobeNewswire

Centessa Pharmaceuticals Announces Second Quarter 2021 Financial Results and Business Updates

16 8 2021 06:00:01 提供 Nasdaq GlobeNewswire

Centessa Pharmaceuticals to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference

07 6 2021 15:15:00 提供 Nasdaq GlobeNewswire